Advantage Alpha Capital Partners LP Boosts Holdings in Omnicell, Inc. (NASDAQ:OMCL)

Advantage Alpha Capital Partners LP increased its stake in shares of Omnicell, Inc. (NASDAQ:OMCL) by 14.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 52,041 shares of the company’s stock after purchasing an additional 6,753 shares during the quarter. Advantage Alpha Capital Partners LP owned 0.11% of Omnicell worth $2,317,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Smartleaf Asset Management LLC lifted its holdings in Omnicell by 51.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 803 shares of the company’s stock valued at $35,000 after purchasing an additional 273 shares in the last quarter. Van ECK Associates Corp lifted its stake in shares of Omnicell by 47.0% in the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company’s stock worth $44,000 after acquiring an additional 315 shares in the last quarter. First Horizon Advisors Inc. increased its position in shares of Omnicell by 36.3% in the 4th quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company’s stock worth $59,000 after purchasing an additional 355 shares during the last quarter. KBC Group NV raised its position in shares of Omnicell by 60.8% during the 4th quarter. KBC Group NV now owns 2,057 shares of the company’s stock valued at $92,000 after acquiring an additional 778 shares in the last quarter. Finally, AlphaQuest LLC boosted its stake in Omnicell by 307.8% in the fourth quarter. AlphaQuest LLC now owns 3,576 shares of the company’s stock valued at $159,000 after acquiring an additional 2,699 shares during the period. Institutional investors and hedge funds own 97.70% of the company’s stock.

Omnicell Stock Down 2.7 %

Shares of OMCL stock opened at $33.94 on Monday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.22 and a current ratio of 1.37. The firm’s 50-day moving average is $39.77 and its 200-day moving average is $42.90. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of 125.71, a PEG ratio of 7.53 and a beta of 0.85. Omnicell, Inc. has a 52-week low of $25.12 and a 52-week high of $55.75.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.12). Omnicell had a return on equity of 3.82% and a net margin of 1.13%. Sell-side analysts predict that Omnicell, Inc. will post 1.09 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have weighed in on OMCL shares. StockNews.com upgraded shares of Omnicell from a “hold” rating to a “buy” rating in a research report on Thursday, March 6th. Benchmark reiterated a “buy” rating and set a $62.00 price target on shares of Omnicell in a report on Tuesday, February 4th. Wells Fargo & Company dropped their price objective on Omnicell from $49.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Monday, January 13th. Bank of America reduced their price target on shares of Omnicell from $54.00 to $46.00 and set a “neutral” rating for the company in a report on Monday, January 6th. Finally, JPMorgan Chase & Co. decreased their price objective on Omnicell from $44.00 to $36.00 and set a “neutral” rating on the stock in a report on Thursday. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $51.00.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.